loading

Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten

pulisher
Feb 01, 2025

Roivant Sciences (NASDAQ:ROIV) Upgraded to "Strong-Buy" at Cantor Fitzgerald - MarketBeat

Feb 01, 2025
pulisher
Jan 28, 2025

Trump Index: 6 Companies Linked to Trump’s Cabinet Worth Watching - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

Trump Index: 6 Companies Linked to Trump's Cabinet Worth Watching - Benzinga

Jan 28, 2025
pulisher
Jan 28, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Jan 28, 2025
pulisher
Jan 25, 2025

Roivant sciences president Eric Venker sells $1.13 million in shares - MSN

Jan 25, 2025
pulisher
Jan 24, 2025

Zweig DiMenna Associates LLC Takes Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells $1,128,000.00 in Stock - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Why Is Andreas Halvorsen Bullish On Roivant Sciences Ltd. (ROIV) Now? - Yahoo Finance

Jan 23, 2025
pulisher
Jan 21, 2025

How Rich Is This Indian-Origin Entrepreneur Who Took On Donald Trump But Is Now…? Check His Net Worth - News24

Jan 21, 2025
pulisher
Jan 20, 2025

What Is Vivek Ramaswamy’s net worth? The Indian American man who took on Trump and then became a confidante - The Financial Express

Jan 20, 2025
pulisher
Jan 19, 2025

Trump Inauguration: Who Is Vivek Ramaswamy and what’s his role in Trump 2.0? - The Financial Express

Jan 19, 2025
pulisher
Jan 18, 2025

Roivant Sciences Sees Unusually High Options Volume (NASDAQ:ROIV) - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Roivant Sciences Ltd. Trade Ideas — LS:A3C4MS - TradingView

Jan 17, 2025
pulisher
Jan 16, 2025

Roivant sciences increases stake in Immunovant with $336.9 million purchase - Investing.com India

Jan 16, 2025
pulisher
Jan 15, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Director Acquires $336,900,200.00 in Stock - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Roivant sciences increases stake in Immunovant with $336.9 million purchase By Investing.com - Investing.com Nigeria

Jan 15, 2025
pulisher
Jan 14, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by JPMorgan Chase & Co. - Defense World

Jan 14, 2025
pulisher
Jan 12, 2025

Is Roivant Sciences (ROIV) the Best Medical Stock to Buy Under $20? - Insider Monkey

Jan 12, 2025
pulisher
Jan 11, 2025

12 Best Medical Stocks To Buy Under $20 - Insider Monkey

Jan 11, 2025
pulisher
Jan 11, 2025

Nordea Investment Management AB Raises Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Jan 11, 2025
pulisher
Jan 10, 2025

ROIVWroivw Latest Stock News & Market Updates - StockTitan

Jan 10, 2025
pulisher
Jan 08, 2025

ROIV Crosses Below Key Moving Average Level - Nasdaq

Jan 08, 2025
pulisher
Jan 07, 2025

Arbutus could benefit from Big Pharma bird flu vaccines: Jefferies - MSN

Jan 07, 2025
pulisher
Jan 06, 2025

Why Ramaswamy Says America Needs a Cultural Shift Towards Excellence for the Sake of US Students - The Times of India

Jan 06, 2025
pulisher
Jan 03, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $17.93 Consensus Target Price from Analysts - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jan 03, 2025
pulisher
Jan 02, 2025

Why Roivant Sciences Ltd. (ROIV) Is Skyrocketing - Yahoo Finance

Jan 02, 2025
pulisher
Jan 01, 2025

10 Firms End 2024 Stronger With Impressive Gains - Insider Monkey

Jan 01, 2025
pulisher
Jan 01, 2025

Strategic Sale: Eric Venker Decides To Exercise Options Worth $3.86M At Roivant Sciences - Benzinga

Jan 01, 2025
pulisher
Dec 31, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells $2,050,704.16 in Stock - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 176,900 Shares of Stock - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Roivant Sciences' president sells common shares worth $4.1 million - Investing.com India

Dec 31, 2024
pulisher
Dec 30, 2024

Principal Financial Group Inc. Has $11.65 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 30, 2024
pulisher
Dec 27, 2024

Roivant Sciences' CIO Mayukh Sukhatme sells $10.6m in shares - Investing.com India

Dec 27, 2024
pulisher
Dec 26, 2024

Eric Venker Sells 100,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) CIO Sells 689,495 Shares of Stock - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

Mayukh Sukhatme Sells 185,946 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

Roivant sciences president Eric Venker sells $1.15 million in shares By Investing.com - Investing.com Nigeria

Dec 26, 2024
pulisher
Dec 26, 2024

Roivant Sciences’ CIO Mayukh Sukhatme sells $10.6m in shares By Investing.com - Investing.com Nigeria

Dec 26, 2024
pulisher
Dec 26, 2024

Roivant Sciences' CIO Mayukh Sukhatme sells $10.6m in shares By Investing.com - Investing.com South Africa

Dec 26, 2024
pulisher
Dec 26, 2024

Roivant sciences president Eric Venker sells $1.15 million in shares - Investing.com

Dec 26, 2024
pulisher
Dec 21, 2024

Barclays PLC Buys 75,609 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 21, 2024
pulisher
Dec 20, 2024

Mayukh Sukhatme Sells 412,584 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat

Dec 20, 2024
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
Kapitalisierung:     |  Volumen (24h):